×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OPK – opko health, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OPK
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/8
05:34 pm
opk
OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains [Yahoo! Finance]
Neutral
Report
OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains [Yahoo! Finance]
1/8
08:31 am
opk
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
1/7
11:06 pm
opk
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
1/7
08:35 am
opk
OPKO Health's ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck [Yahoo! Finance]
Low
Report
OPKO Health's ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck [Yahoo! Finance]
1/7
08:00 am
opk
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
Low
Report
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
12/26
02:02 am
opk
OPKO Health, Inc. (NASDAQ: OPK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
12/18
11:06 pm
opk
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Neutral
Report
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
12/16
04:19 pm
opk
GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/13
05:05 pm
opk
Form 4 OPKO HEALTH, INC. For: Dec 13 Filed by: FROST PHILLIP MD ET AL
Low
Report
Form 4 OPKO HEALTH, INC. For: Dec 13 Filed by: FROST PHILLIP MD ET AL
12/11
05:22 pm
opk
Form 4 OPKO HEALTH, INC. For: Dec 11 Filed by: FROST PHILLIP MD ET AL
Low
Report
Form 4 OPKO HEALTH, INC. For: Dec 11 Filed by: FROST PHILLIP MD ET AL
11/29
03:21 pm
opk
Form 4 OPKO HEALTH, INC. For: Nov 29 Filed by: FROST PHILLIP MD ET AL
Neutral
Report
Form 4 OPKO HEALTH, INC. For: Nov 29 Filed by: FROST PHILLIP MD ET AL
11/22
05:17 pm
opk
Form 4 OPKO HEALTH, INC. For: Nov 22 Filed by: FROST PHILLIP MD ET AL
Low
Report
Form 4 OPKO HEALTH, INC. For: Nov 22 Filed by: FROST PHILLIP MD ET AL
11/20
07:21 pm
opk
Form 4/A OPKO HEALTH, INC. For: Nov 08 Filed by: FROST PHILLIP MD ET AL
Medium
Report
Form 4/A OPKO HEALTH, INC. For: Nov 08 Filed by: FROST PHILLIP MD ET AL
11/15
04:40 pm
opk
Form SC 13D/A OPKO HEALTH, INC. Filed by: FROST PHILLIP MD ET AL
Low
Report
Form SC 13D/A OPKO HEALTH, INC. Filed by: FROST PHILLIP MD ET AL
11/14
05:52 pm
opk
Form 4 OPKO HEALTH, INC. For: Nov 14 Filed by: FROST PHILLIP MD ET AL
Low
Report
Form 4 OPKO HEALTH, INC. For: Nov 14 Filed by: FROST PHILLIP MD ET AL
11/13
04:31 pm
opk
Form SC 13G OPKO HEALTH, INC. Filed by: Rubric Capital Management LP
Low
Report
Form SC 13G OPKO HEALTH, INC. Filed by: Rubric Capital Management LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/5
OPKO Health's BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test
29.2%
4/20 Form 4 Opko Health, Inc. For: Apr 17 Filed by: FROST PHILLIP MD ET AL 16.5%
3/17 OPKO Health's BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19) 13.1%
3/4 Form 4 Opko Health, Inc. For: Mar 03 Filed by: Frost Gamma Investments Trust 12.2%
3/13 Form 4 Opko Health, Inc. For: Mar 12 Filed by: Japour Anthony J 11.8%
4/6 Form 4 Opko Health, Inc. For: Apr 03 Filed by: FROST PHILLIP MD ET AL 11.6%
6/28 Novitas Issues Proposed Local Coverage Determination for the 4Kscore® Test 9.9%
4/8 Form 4 Opko Health, Inc. For: Apr 07 Filed by: Frost Gamma Investments Trust 7.8%
9/23 Form 8-K Opko Health, Inc. For: Sep 21 6.5%
3/10 Opko Health Inc. (NASDAQ: OPK) had its price target raised by analysts at Piper Sandler from to . 6.2%
4/20 Form 4 Opko Health, Inc. For: Apr 17 Filed by: FROST PHILLIP MD ET AL 16.5%
3/17 OPKO Health's BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19) 13.1%
3/4 Form 4 Opko Health, Inc. For: Mar 03 Filed by: Frost Gamma Investments Trust 12.2%
3/13 Form 4 Opko Health, Inc. For: Mar 12 Filed by: Japour Anthony J 11.8%
4/6 Form 4 Opko Health, Inc. For: Apr 03 Filed by: FROST PHILLIP MD ET AL 11.6%
6/28 Novitas Issues Proposed Local Coverage Determination for the 4Kscore® Test 9.9%
4/8 Form 4 Opko Health, Inc. For: Apr 07 Filed by: Frost Gamma Investments Trust 7.8%
9/23 Form 8-K Opko Health, Inc. For: Sep 21 6.5%
3/10 Opko Health Inc. (NASDAQ: OPK) had its price target raised by analysts at Piper Sandler from to . 6.2%
TOP News Decliners
3/9
Edited Transcript of OPK earnings conference call or presentation 26-Feb-20 9:30pm GMT [Yahoo! Finance News]
-26.0%
5/7 Q1/2019 3/31/2019 EPS -0.140 ZacksConsensus -0.060 ActVsEst (0.080) - Miss -14.3%
10/24 OPKO Health, Inc. Announces Pricing of its Offering of Common Stock -14.3%
10/24 Form 424B5 Opko Health, Inc. -14.2%
3/13 Coronavirus activity roundup - healthcare [Seeking Alpha] -11.6%
3/7 Opko Health Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at Piper Sandler. -10.5%
3/20 Form 4 Opko Health, Inc. For: Mar 19 Filed by: Frost Gamma Investments Trust -8.5%
10/21 OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency -7.8%
11/5 OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results -7.5%
5/13 Form 4 Opko Health, Inc. For: May 10 Filed by: FROST PHILLIP MD ET AL -6.7%
5/7 Q1/2019 3/31/2019 EPS -0.140 ZacksConsensus -0.060 ActVsEst (0.080) - Miss -14.3%
10/24 OPKO Health, Inc. Announces Pricing of its Offering of Common Stock -14.3%
10/24 Form 424B5 Opko Health, Inc. -14.2%
3/13 Coronavirus activity roundup - healthcare [Seeking Alpha] -11.6%
3/7 Opko Health Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at Piper Sandler. -10.5%
3/20 Form 4 Opko Health, Inc. For: Mar 19 Filed by: Frost Gamma Investments Trust -8.5%
10/21 OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency -7.8%
11/5 OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results -7.5%
5/13 Form 4 Opko Health, Inc. For: May 10 Filed by: FROST PHILLIP MD ET AL -6.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: